Health Care & Life Sciences » Pharmaceuticals | Kaken Pharmaceutical Co. Ltd.

Kaken Pharmaceutical Co. Ltd.

Kaken Pharmaceutical Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY445.79
Market Cap
JPY201.72 B
Shares Outstanding
45.94 M
Public Float
28.99 M

Profile

Address
2-28-8 Honkomagome
Tokyo Tokyo 113
Japan
Employees -
Website http://www.kaken.co.jp
Updated 07/08/2019
Kaken Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products, medical devices, agrochemicals, and animal health products in Japan. Its operations are carried out through the following business divisions: Pharmaceuticals and Medical Devices, Agrochemicals and Animal Health Products, Overseas Activity, Research & Development, and Licensing Opportunities. The Pharmaceuticals and Medical Devices division offers artz(anti-osteoarthritis), clenafin (topical onychomycosis treatment product), seprafilm (anti-adhesive absorbent barrier), lipidil (anti-hyperlipidemia product), fiblast spray (wound-healing product), mentax (anti-trichophyton product) and generic drugs.

Financials

View All
Created with Highcharts 5.0.14Kaken Pharmaceutical Co. Ltd.Net Income. Fiscal year is April-March. All values JPY Millions.9 7359 73512 12212 12221 14321 14322 01722 01719 04319 04317 77517 77520142015201620172018201905k10k15k20k25k
Created with Highcharts 5.0.14Kaken Pharmaceutical Co. Ltd.Sales/Revenue. Fiscal year is April-March. All values JPY Millions.88 94688 94693 88993 889109 730109 730101 991101 99198 43298 43294 16794 167201420152016201720182019025k50k75k100k125k

Tetsuo Onuma
President & Representative Director
Chikara Ieda
Director, General Manager-Research & Development